We bring together talent and expertise from across the University of Minnesota to use stem cell biology to advance regenerative medicine therapies for devastating disorders and to provide education and training for the stem cell scientists of tomorrow.


Check out the SCI Connection Board!

Opportunities wanted and available are now online! 

Our Research

Our Education Programs

The bioscience and medical industries and academic research programs need intelligent, engaged, well-trained talent to fill jobs in the rapidly expanding field of regenerative medicine. The Stem Cell Institute prepares students who are ready to meet this need and who are eager to move the next generation of research forward. Learn more about our graduate programs:

In the News

Jim Gass
June 23, 2016

Jim Gass received a stem cell treatment in Mexico in the hopes of improving after a stroke. The devastating outcome of this procedure is outlined in this article from The New York Times.

Here at the SCI, we do not treat patients--we perform the basic science research that is needed to find promising new treatments and to establish that they are safe and effective--but we do we receive many inquiries about stem cell therapies. We want to help everyone get accurate information as they educate themselves. Stem cells hold incredible potential but, as this article illustrates, we have much to learn about them that is better learned in a laboratory rather than at a patient's expense.

We suggest you also visit www.closerlookatstemcells.org, a reputable site published by the International Society for Stem Cell Research (ISSCR).

Regenerative Medicine Minnesota logo
May 23, 2016

Regenerative Medicine Minnesota is working to create the infrastructure and knowledge needed to bring regenerative therapies to Minnesotans and to bring Minnesota to the forefront of regenerative medicine. The second year's funding of Educational Programs and Biobusiness/Biotechnology are announced today.

Spinal Cord Society Image of Cells
April 28, 2016

Drs. Eric Holmberg, PhD, Research Director of the Spinal Cord Society, and Shu-xin Zhang, MD, PhD, a contracted researcher with the Spinal Cord Society, will be spending time at Dr. Ann Parr's Stem Cell Institute lab this week to start work on their collaboration for a combination therapy to treat chronic spinal cord injury. Drs. Holmberg and Zhang will be demonstrating their technique to ablate the glial scar that develops at the site of injury using a photo-toxic chemical probe called rose-Bengal. Scar ablation provides a more permissive physical and biochemical environment for axon sprouting. Once the technique is optimized, human induced pluripotent stem cell (hIPSC) derived oligodendrocyte precursor cells (OPCs) derived by Dr. Parr's lab will be transplanted following scar ablation. The hypothesis is that the cells will survive and integrate into the injured spinal cord and provide functional recovery. 

This collaborative work was recently funded with the Spinal Cord Injury and Traumatic Brain Injury Grant from the Minnesota legislature.
Dr. Andy Grande
March 25, 2016

Stem Cell Institute faculty members have active clinical and research programs outside the SCI. Learn more about how Dr. Grande helped a patient overcome debilitating pain through brain surgery.

Weekly Research Conference

Meets weekly in Room 1-110
McGuire Translational Research Facility (MTRF, next to Lion's Research Building)
[map] [shuttle schedule]

Wednesday, June 29, 2016 - 4:00pm

Modeling cardiopharyngeal mesoderm to generate second heart field and craniofacial muscle derivatives

Sunny Chan
Sunny Chan, PhD
Kyba Laboratory, UMN

Wednesday, July 6, 2016 - 4:00pm

Retinal pigment epithelial (RPE) differentiation from conjunctival cell-derived iPS cells

Zhaohui Geng
Zhaohui Geng, PhD
Dutton Laboratory, UMN

Wednesday, July 13, 2016 - 4:00pm

Unraveling the regenerative potential of pluripotent-derived engrafted satellite cells: are we ready for the long run?

Tania Incitti
Tania Incitti, PhD
Perlingeiro Laboratory, UMN